Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of asymptomatic hyperuricemia: Integrated Diabetes & Endocrine Academy (IDEA) consensus statement
Rahul Valsaraj, Awadhesh Kumar Singh, Kalyan Kumar Gangopadhyay, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 2, pp. 93-100
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout
Shuaiwei Song, Xintian Cai, Junli Hu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 23
Associations of triglyceride-glucose index with hyperuricemia among Royal Thai Army personnel
Sethapong Lertsakulbunlue, Tanatip Sangkool, Varathpavee Bhuriveth, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis
Mainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay
Acta Diabetologica (2022) Vol. 59, Iss. 6, pp. 783-791
Closed Access | Times Cited: 24
Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-dependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the framework of preventive counseling. Methodological Guidelines
О. М. Драпкина, N. S. Karamnova, А. V. Kontsevaya, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2021) Vol. 20, Iss. 5, pp. 2952-2952
Open Access | Times Cited: 30
Longitudinal associations between metabolic score for visceral fat and hyperuricemia in non-obese adults
Xingzhen Liu, D Chen, Xia Xu, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 10, pp. 1751-1757
Closed Access | Times Cited: 28
Genome analysis of a newly isolated Lysinibacillus fusiformis–YC01 for biodegrading inosine and guanosine
Yu Zhang, Xiaoyu Cao, Jingyuan Cai, et al.
Biodegradation (2025) Vol. 36, Iss. 2
Closed Access
Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3–5 patients with asymptomatic hyperuricemia: a network meta-analysis
Jiaojiao Chen, Yi Zhang, Yinglin Wang, et al.
Renal Failure (2025) Vol. 47, Iss. 1
Open Access
The Effect of Low and Moderate Exercise on Hyperuricemia: Protocol for a Randomized Controlled Study
Yuning Hou, Renyan Ma, Song Gao, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 23
Effects of allisartan‐isoproxil‐based combination antihypertensive regimen in hypertensive patients with microalbuminuria or hyperuricemia
Ningling Sun, Hongyi Wang
Journal of Clinical Hypertension (2024) Vol. 26, Iss. 3, pp. 241-250
Open Access | Times Cited: 3
Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
Shengzhao Zhang, Ting Xu, Qingyang Shi, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18
L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition
Yang Yang, Cuiting Lin, Qiang Zheng, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Establishment and validation of prediction model for atherosclerotic cardiovascular disease in patients with hyperuricemia
Xingchen Du, Fangfang Chen, Yisheng He, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 6
Closed Access | Times Cited: 2
Association between consumption of flavonol and its subclasses and chronic kidney disease in US adults: an analysis based on National Health and Nutrition Examination Survey data from 2007–2008, 2009–2010, and 2017–2018
Peijia Liu, Leile Tang, Guixia Li, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 2
Serum Uric Acid Levels Associated with Outcomes of Neurodegenerative Disorders and Brain Health: Findings from the UK Biobank
Zihao Jiang, Jieyu Chen, Siqi Wu, et al.
The journal of nutrition health & aging (2024) Vol. 28, Iss. 9, pp. 100319-100319
Open Access | Times Cited: 1
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study
Antonio Ruiz‐García, A Serrano-Cumplido, Ezequiel Arranz-Martínez, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4884-4884
Open Access | Times Cited: 1
Association between serum carotenoids and hyperuricemia: a cross-sectional study based on NHANES 2001–2006
Pengfei Chen, Lina Miao, Lixiao Zhang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Neck circumference is an independent risk factor for hyperuricemia within 3 years in women: a longitudinal study
Ping An, Kang Chen, Anping Wang, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 12, pp. 3757-3767
Closed Access | Times Cited: 9
An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy
Ronald J. Hogg
Pediatric Nephrology (2021) Vol. 37, Iss. 5, pp. 947-958
Closed Access | Times Cited: 8
Efficacy and safety of urate‐lowering treatments in patients with hyperuricemia: A comprehensive network meta‐analysis of randomized controlled trials
Shanshan Sun, Donghu Zhang, Yue Shi, et al.
Journal of Clinical Pharmacy and Therapeutics (2020) Vol. 45, Iss. 4, pp. 729-742
Open Access | Times Cited: 6
Prevalence of hyperuricemia and its correlation with metabolic syndrome in young adults: a cross-sectional study in eastern China
Bohan Lu, Cuirong Hu, Jifang Lu, et al.
Research Square (Research Square) (2024)
Open Access
Endocrine Complications in Hepatic Glycogen Storage Diseases: A Long-term Perspective
Ja Hye Kim, Yena Lee, Soojin Hwang, et al.
Experimental and Clinical Endocrinology & Diabetes (2024) Vol. 133, Iss. 02, pp. 83-91
Closed Access
Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
Guanting Li, Yu-Long Hu, Han Zhao, et al.
Advanced Science (2024)
Open Access
Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review
Kaiqing Li, Xue Xia, Tong Fu, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e40975-e40975
Open Access
Hyperuricemia: Features of the Diet
O. B. Shvabskaya, O. V. Izmailova, N. S. Karamnova, et al.
Rational Pharmacotherapy in Cardiology (2022) Vol. 17, Iss. 6, pp. 889-899
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top